Full-Time

Senior Account Enablement Manager

Inizio

Inizio

5,001-10,000 employees

Guides clinical development and commercialization

No salary listed

London, UK

In Person

Category
Business & Strategy (1)
Required Skills
Forecasting
Hubspot
Salesforce
Data Analysis
Requirements
  • Proven experience in sales operations, account management, or commercial enablement within a global organization.
  • Strong leadership and team management skills, with experience leading cross-regional teams.
  • Excellent communication and stakeholder engagement abilities.
  • Familiarity with CRM tools (e.g., HubSpot, Salesforce) and sales analytics platforms.
  • Ability to manage multiple priorities and drive alignment across diverse teams.
Responsibilities
  • Lead and manage the Account Enablement team, fostering a culture of excellence, collaboration, and continuous improvement.
  • Develop and apply consistent processes and tools to implement strategic account management processes across Ignite (as defined and utilized by Ignite Sales Executive team)
  • Align support of account enablement team to Ignite top 10 priority accounts
  • Drive best practices across pursuit readiness, lead tracking, account planning, and client relationship visibility.
  • Act as the central liaison between Sales Executives, vertical delivery teams, and commercial enablement, ensuring efficient follow-up on pipeline activity and meeting preparation.
  • Track client relationships, role/activity movement, and account-level performance against goals, supporting strategic decision-making.
  • Partner with Business Intelligence and Reporting lead to plan and prepare materials for quarterly business reviews and ongoing account planning discussions
  • Provide ongoing research and analysis to provide Sales Executives and Account teams with news and industry insights to better position Ignite for success
  • Drive consistent HubSpot adoption across the Account Enablement, Sales Executive, and seller-doer teams by reinforcing required fields, account/pursuit tagging, meeting and activity logging expectations, and the “minimum viable” data needed to run account reviews and forecasting
  • Partner with Enterprise CRM/Commercial Ops to translate system changes into practical Ignite workflows (job aids, quick trainings, and in-the-flow guidance) and serve as a point of escalation for user issues that impact account visibility. Resolve in partnership with Ignite point of contact within Commercial Ops team.
  • Monitor and improve data quality by flagging recurring gaps (e.g., missing close dates, inconsistent stages, untagged opportunities) and coordinating follow-ups with Sales Execs and seller-doers to improve compliance and accuracy over time (supported by business partner on Commercial Ops team).
  • Standardize account planning and pipeline management routines across accounts by aligning on common definitions, templates, and “ways of working” (e.g., what constitutes a qualified opportunity, stage expectations, and handoff points between Sales and delivery teams).
  • Support alignment on key commercial metrics (pipeline, win rate, days-to-sell, average deal size, forecast accuracy, account health indicators) by partnering with Business Intelligence/Reporting to document definitions, reconcile inconsistencies, and drive adoption of a single set of Ignite reporting standards.
  • Capture best practices and process improvements across legacy teams and geographies, identifying friction points and recommending pragmatic enhancements that reduce rework, improve speed-to-respond, and strengthen account-level visibility for leadership and Sales.
  • Enable region-specific GTM and account planning activities, providing structure and visibility to market-aligned growth teams, as needed.
  • Partner with Client Solutions and Marketing to ensure tools, templates, and processes are pulled through to account focused discussions
Desired Qualifications
  • Experience in health and life sciences or consulting preferred.
  • Experience in an Inizio Ignite Consulting or similar service delivery role is preferred.

Inizio helps health and life sciences companies develop and commercialize products to maximize patient access. It uses a connected suite of capabilities and expert guidance to navigate assets through their entire lifecycle with tailored strategies. Unlike firms that offer single services, Inizio combines multiple capabilities in an end-to-end approach focused on reducing complexity and ensuring lifecycle support. Its goal is to bring therapies to patients faster and more effectively by coordinating development, regulatory, market access, and commercialization activities to maximize value and treatment outcomes.

Company Size

5,001-10,000

Company Stage

N/A

Total Funding

N/A

Headquarters

New York City, New York

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Colin Stanley's CCO appointment on February 6, 2025, drives commercialization growth with 25 years' experience.
  • Patrick Giordani as SVP AI Solutions Architect bolsters AI innovation in medical affairs communications.
  • Nazaré unites 150 experts to enhance employee performance via immersive learning experiences.

What critics are saying

  • Intelligent Automation Congress on March 3-4, 2026, erodes edge with superior AI event automation.
  • Nazaré launch cannibalizes Intelligent Congress budgets, diverting funds to internal learning.
  • Patrick Giordani's AI fails by end-2026, causing client exodus to IA Congress AI networks.

What makes Inizio unique

  • Intelligent Congress integrates strategy, design, delivery, and measurement across congress lifecycles.
  • Inizio supports 175 congresses yearly for 100% of top 20 pharma companies across 50 countries.
  • Four-step framework captures real-time insights from over 25,500 attendees and 1,000 HCP engagements.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Inizio who can refer or advise you

Benefits

Health Insurance

401(k) Retirement Plan

Performance Bonus

Professional Development Budget

Hybrid Work Options

Company News

PR Newswire
Feb 6th, 2025
Inizio Accelerates Growth With A Trio Of Strategic Leadership Appointments

LONDON, Feb. 6, 2025 /PRNewswire/ -- Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.Stepping into the CCO role, Colin brings over 25 years of sector experience and a proven track record in business growth in the industry, from CRO and commercialization

Bio-IT World
Oct 20th, 2024
Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

Inizio Medical, the leading provider of Medical Affairs and communications solutions, today announced the appointment of Patrick Giordani as Senior Vice President, AI Solutions Architect.

Bio-IT World
Oct 14th, 2024
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

Bio-IT World Inc is immensely proud that Matt has chosen to join Inizio Medical and contribute to its mission of providing exceptional medical communications and specialized solutions.

PR Newswire
Oct 18th, 2023
Inizio Engage Launches New Global Powerhouse Learning Brand, Nazaré

FORT WASHINGTON, Pa., Oct. 18, 2023 /PRNewswire/ -- Inizio Engage has announced the launch of Nazaré, a new learning and capability brand. Nazaré brings together 150+ experts in learning, life sciences, creativity, technology, and behavioral science. Nazaré is set to transform workplace learning in order to help companies maintain their leadership in evolving competitive landscapes by unlocking the potential of their people.The new global learning and capability brand will be part of the Experience Design (XD) specialist area within Inizio Engage. This means Nazaré will draw on the rest of Inizio Engage XD's in-house creative and executional capabilities in live events, environments, film, digital, and immersive technologies, as well as considering learning experience design more holistically alongside employee engagement.Nazaré brings together Axiom, Cormis, Logicearth Learning Services and Ashfield Excellence Academy under one brand to support global organizations with a range of learning and capability programs, with an unparalleled level of expertise in end-to-end life sciences learning support for pharmaceutical and biotech companies across the product lifecycle. Nazaré will focus on designing and delivering world-class learning experiences that inspire an immediate and lasting change in performance.Nazaré harnesses science, creativity, and technology to challenge how the Learning & Development industry creates impact for businesses

PR Newswire
Sep 14th, 2023
Innovative Collaboration: Buzzreach And Oncoshot Spearhead Clinical Trial Advancements In Japan

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specialises in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform.Mr Taketeru Inokawa (left) and Dr Huren Sivaraj (right) during the MOU signing ceremony in Singapore.The collaboration will extend to Oncoshot's strategic contract research organisation and pharmaceutical partners. Together, they will focus on recruiting participants for upcoming studies scheduled to begin in Q1 2024."This collaboration marks a significant step in Oncoshot's vision of creating a cancer cohort discovery platform and upcoming national-level clinical trials ecosystems and hospitals globally," said Oncoshot CEO Dr Huren Sivaraj.Central to this partnership is the cost-free infrastructure designed to facilitate the real-time exchange of aggregated insights. This ground-breaking initiative is set to synergise their complementary strengths to enhance various clinical trial aspects throughout Japan, including feasibility assessments, participant screening, and enrolment. Japan is currently ranked as the third-largest pharmaceutical market worldwide